Skip to main content
July 3, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
BRCA 2
Breast Cancer Treatment
PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.
By Dr. C.H. Weaver M.D.
Apr 30, 2022
Ovarian Cancer Treatment
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Nov 19, 2021
Breast Cancer Overviews
Precision Cancer Medicines and Breast Cancer
By Dr. C.H. Weaver M.D.
Feb 9, 2022
Breast Cancer Survivorship
Hereditary Breast and Ovarian Cancer: What you need to know about risk
By Dr. C.H. Weaver M.D.
Oct 9, 2021
Breast Cancer Overviews
Male BRCA2 Carriers Have Increased Lifetime Risk of Breast Cancer
By CancerConnect
May 26, 2022
Breast Cancer
CHEK2 Gene Mutations Increase Breast Cancer Risk
By CancerConnect
Oct 13, 2021
CLOSE
CLOSE
CLOSE
CLOSE